Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling

Daniel C. Berwick(St George's, University of London), Kirsten Harvey(Medway School of Pharmacy)
Molecular Neurodegeneration
January 19, 2017
10.1186/s13024-017-0153-4
Cited by 52

Related Papers

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>
|Science|2004|3.5k
Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER
|Science|2016|489
Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity
|Frontiers in Molecular Neuroscience|2016|69
Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
|Scientific Reports|2024|17